Fangchinoline Inhibits Zika Virus by Disrupting Virus Internalization
ACS Infectious Diseases · 2024
DOI: 10.1021/acsinfecdis.4c00600 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Shaokang Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China. Hauptthemen laut MEDLINE: Zika Virus, Antiviral Agents, Zika Virus Infection, Benzylisoquinolines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Projects for ???Major New Drugs Innovation and Development???.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
ORCID-Profile: Ruiyuan Cao, Wu Zhong
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Projects for ???Major New Drugs Innovation and Development???
Zitieren
APA
Yang, S., Yang, X., Wang, Z., Li, W., Cao, R., & Zhong, W. (2024). Fangchinoline Inhibits Zika Virus by Disrupting Virus Internalization. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00600
Vancouver
Yang S, Yang X, Wang Z, Li W, Cao R, Zhong W. Fangchinoline Inhibits Zika Virus by Disrupting Virus Internalization. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00600
BibTeX
@article{Yang2024,
author = {Yang, Shaokang and Yang, Xiaotong and Wang, Zhuang and Li, Wei and Cao, Ruiyuan and Zhong, Wu},
title = {Fangchinoline Inhibits Zika Virus by Disrupting Virus Internalization},
journal = {ACS Infectious Diseases},
year = {2024},
doi = {10.1021/acsinfecdis.4c00600}
}
EUVIMED